|
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy |
|
|
|
Title: |
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy |
Author: |
Passaro, A. Mancuso, P. Gandini, S. Spitaleri, G. Labanca, V. Guerini-Rocco, E. Barberis, M. Catania, C. Del Signore, E. de Marinis, F. Bertolini, F. |
Appeared in: |
Clinical and translational oncology |
Paging: |
Volume 22 () nr. 4 pages 621 |
Year: |
2019-08-20 |
Contents: |
|
Publisher: |
Springer International Publishing, Cham |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|